Asston Pharmaceu

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0SJX01015
  • NSEID:
  • BSEID: 544445
INR
93.00
-2.13 (-2.24%)
BSENSE

Dec 05

BSE+NSE Vol: 4000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 56.22% vs 145.15% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 42.21% vs 152.04% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 24.37% vs 5.92% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 58.47% vs 130.10% in Mar 2024

Compare Profit and Loss Results of Asston Pharmaceu
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
25.00
44.00
-19.00
-43.18%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
25.00
44.00
-19.00
-43.18%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-1.00
1.00
100.00%
Raw Materials Consumed
14.00
34.00
-20.00
-58.82%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1.00
3.00
-2.00
-66.67%
Operating Expenses
0.00
1.00
-1.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
0.00
1.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
19.00
39.00
-20.00
-51.28%
Operating Profit (PBDIT) excl Other Income
5.00
5.00
0.00
0.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
6.00
5.00
1.00
20.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
5.00
4.00
1.00
25.00%
Depreciation
0.00
1.00
-1.00
-100.00%
Profit Before Taxation & Exceptional Items
5.00
3.00
2.00
66.67%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
3.00
2.00
66.67%
Provision for Tax
1.00
0.00
1.00
0%
Profit After Tax
3.00
2.00
1.00
50.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
3.00
11.00
-8.00
-72.73%
Profit Available for appropriations
7.00
14.00
-7.00
-50.00%
Appropriations
7.00
14.00
-7.00
-50.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
6.14
4.51
1.63
36.14%
Profit And Loss - Net Sales
Net Sales 25.04 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 56.22% vs 145.15% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.44 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 42.21% vs 152.04% in Mar 2024

Profit And Loss - Interest
Interest 0.95 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 24.37% vs 5.92% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 3.85 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 58.47% vs 130.10% in Mar 2024